Effects of α-galactosylceramide (KRN7000), interleukin-12 and interleukin-7 on phenotype and cytokine profile of human Vα24+ Vβ11+ T cells

Immunology

Volumn 98, Issue 4, 1999, Pages 557-563

  Van Der Vliet, H J J ^a,b   Nishi, N ^a   Koezuka, Y ^c   Peyrat, M A ^d   Von Blomberg, B M E ^b   Van Den Eertwegh, A J M ^a   Pinedo, H M ^a,b   Giaccone, G ^a   Scheper, R J ^b  

^a Department of Medical Oncology ^*  (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c KIRIN BREWERY CO LTD   (Japan)

^d INSTITUT DE BIOLOGIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

1 O (ALPHA GALACTOPYRANOSYL) 2 HEXACOSANOYLAMINO 1,3,4 OCTADECANETRIOL; INTERLEUKIN 12; INTERLEUKIN 7;

ANTIGEN PRESENTING CELL; ARTICLE; AUTOIMMUNITY; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; DRUG EFFECT; HUMAN; HUMAN CELL; IMMUNE RESPONSE; KILLER CELL; MOLECULAR CLONING; MOLECULAR RECOGNITION; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ADULT; ANTINEOPLASTIC AGENTS; CALCIMYCIN; CELLS, CULTURED; CLONE CELLS; CYTOKINES; FEMALE; FLOW CYTOMETRY; GALACTOSYLCERAMIDES; GRANZYMES; HUMANS; INTERFERON TYPE II; INTERLEUKIN-12; INTERLEUKIN-4; INTERLEUKIN-7; IONOPHORES; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MALE; SERINE ENDOPEPTIDASES; TETRADECANOYLPHORBOL ACETATE; TH1 CELLS;

EID: 0033460235     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1999.00920.x     Document Type: Article

References (33)

1. + and CD4 CD8 T cells in mice and humans. J Exp Med 180, 1097.
2. + T-cell antigen receptor α chain in mice. Proc Natl Acad Sci USA 88, 7518.
3. 3. DELLABONA P., CASORATI G., FRIEDLI B. et al. (1993) In vivo persistence of expanded clones specific for bacterial antigens within the human T cell receptor α/β CD4 CD8 subset. J Exp Med 177, 1763.
4. 4. DELLABONA P., PADOVAN E., CASORATI G., BROCKHAUS M. & LANZAVECCHIA A. (1994) An invariant Vα24-JαQ/VβII T cell receptor is expressed in all individuals by clonally expanded CD4 CD8 T cells. J Exp Med 180, 1171.
5. 5. PORCELLI S., YOCKEY C.E., BRENNER M.B. & BALK S.P. (1993) Analysis of T cell receptor (TCR) expression by human peripheral blood CD4 CD8 α/β T cells demonstrates preferential use of several Vβ genes and an invariant α chain. J Exp Med 178, 1.
6. 6. PORCELLI S.A. (1995) The CDI family: a third lineage of antigen presenting molecules. Adv Immunol 59, 1.
7. 7. BECKMAN E.M. & BRENNER M.B. (1995) MHC class I-like, class II-like and CD1 molecules: distinct roles in immunity. Immunol Today 16, 349.
8. 8. CASTANO A.R., TANGRI S., MILLER J.E. et al. (1995) Peptide binding and presentation by mouse CD1. Science 269, 223.
9. 9. BROSSAY L., CHIODA M., BURDIN N. et al. (1998) CD1d-mediated recognition of an α-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution. J Exp Med 188, 1521.
10. 10. SPADA F.M., KOEZUKA Y. & PORCELLI S.A. (1998) CD1d-restricted recognition of synthetic glycolipid antigens by human natural killer T cells. J Exp Med 188, 1529.
11. + CD4 CD8 T cells. J Exp Med 186, 109.
12. + T cells produce large amounts of IL-4 and IFN-γ upon activation by anti-CD3 or CD1. J Immunol 159, 2240.
13. 13. CUI J., SHIN T., KAWANO T. et al. (1997) Requirement for Vα14 NKT cells in IL-12-mediated rejection of tumors. Science 278, 1623.
14. 14. WILSON S.B., KENT S.C., PATTON K.T. et al. (1998) Extreme Th1 bias of invariant Vα24JαQ T cells in type I diabetes. Nature 391, 177.
15. + NK T cells associated with disease development in autoimmune-prone mice. J Immunol 156, 4035.
16. 16. SUMIDA T., SAKAMOTO A., MURATA H. et al. (1995) Selective reduction of T cells bearing invariant Vα24JαQ antigen receptor in patients with systemic sclerosis. J Exp Med 182, 1163.
17. 17. LEITE-DE-MORAES M.C., MOREAU G., ARNOULD A. et al. (1998) IL-4-producing NK T cells are biased towards IFN-γ production by IL-12. Influence of the microenvironment on the functional capacities of NK T cells. Eur J Immunol 28, 1507.
18. 18. KAWAMURA T., TAKEDA K., MENDIRATTA S.K. et al. (1998) Critical role of NK1+ T cells in IL-12-induced immune responses in vivo. J Immunol 160, 16.
19. 19. GOMBERT J.M., TANCREDE-BOHIN E., HAMEG A. et al. (1996) IL-7 reverses NK1+ T cell-defective IL-4 production in the non-obese diabetic mouse. Int Immunol 8, 1751.
20. 20. NAKAGAWA R., MOTOKI K., UENO H. et al. (1998) Treatment of hepatic metastasis of the colon26 adenocarcinoma with an α-galactosylceramide, KRN7000. Cancer Res 58, 1202.
21. 21. LIU C.C., YOUNG L.H.Y. & YOUNG J.D.E. (1996) Mechanisms of disease: lymphocyte-mediated cytolysis and disease. N Engl J Med 335, 1651.
22. 22. TALANIAN R.V., YANG X.H., TURBOV J. et al. (1997) Granule-mediated killing: pathways for granzyme B-initiated apoptosis. J Exp Med 186, 1323.
23. + T cell subset in peripheral blood from healthy individuals contains activated and apoptosis-prone cells. Immunology 93, 383.
24. 24. COUEDEL C., PEYRAT M.A., BROSSAY L. et al. (1998) Diverse CD1d-restricted reactivity patterns of human T cells bearing 'invariant' AV24BV11 TCR. Eur J Immunol 28, 4391.
25. 25. DAVODEAU F., PEYRAT M.A., NECKER A. et al. (1997) Close phenotypic and functional similarities between human and murine αβ T-cell expressing invariant TCR α chains. J Immunol 158, 5603.
26. 26. NIEDA M., NICOL A., KOEZUKA Y. et al (1999) Activation of human Vα24NKT cells by α-glycosylceramide in a CD1d-restricted and Vα24TCR-mediated manner. Hum Immunol 60, 10.
27. 27. PRUSSIN C. & FOSTER B. (1997) TCR Vα24 and Vβ11 coexpression defines a human NK1 T cell analog containing a unique Th0 subpopulation. J Immunol 159, 5862.
28. 28. LANIER L.L., CHANG C. & PHILLIPS J.H. (1994) Human NKR-PIA. A disulfide-linked homodimer of the C-type lectin superfamily expressed by a subset of NK and T lymphocytes. J Immunol 153, 2417.
29. 29. POGGI A., RUBARTELLI A., MORETTA L. & ZOCCHI M.R. (1997) Expression and function of NKRP1A molecule on human monocytes and dendritic cells. Eur J Immunol 27, 2965.
30. 30. EXLEY M., PORCELLI S., FURMAN M., GARCIA J. & BALK S. (1998) CD161 (NKR-P1A) costimulation of CD1d-dependent activation of human T cells expressing invariant Vα24JαQ T cell receptor α chains. J Exp Med 188, 867.
31. 31. KAWANO T., CUI J., KOEZUKA Y. et al. (1998) Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Vα14 NKT cells. Proc Natl Acad Sci USA 95, 5690.
32. 32. SALCEDO T.W., AZZONI L., WOLF S.F. & PERUSSIA B. (1993) Modulation of perforin and granzyme messenger RNA expression in human natural killer cells. J Immunol 151, 2511.
33. 33. CHOUAIB S., CHEMINI J., BANI L. et al. (1994) Interleukin 12 induces the differentiation of major histocompatibility complex class-I primed cytotoxic T-lymphocyte precursors into allospecific cytotoxic effectors. Proc Natl Acad Sci USA 91, 12659.